Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
30,25 USD | +0,30% |
|
+1,34% | +18,81% |
Attività
Numero di dipendenti: 186
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67,84% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67,84% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Nello Mainolfi
FOU | Founder | 45 | 01/09/15 |
Bruce Jacobs
DFI | Director of Finance/CFO | 54 | 15/07/19 |
Juliet Williams
CTO | Chief Tech/Sci/R&D Officer | - | 05/05/21 |
Kevin Dushney
CTO | Chief Tech/Sci/R&D Officer | - | 03/02/21 |
Jared Gollob
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/18 |
Vijay Sabesan
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/12/21 |
Jeremy Chadwick
COO | Chief Operating Officer | 61 | 22/05/23 |
Investor Relations Contact | - | 01/07/23 | |
Aimee Mishkin
LAW | General Counsel | - | 01/04/20 |
Melissa Brody
PRN | Corporate Officer/Principal | - | 02/11/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 28/03 |
John Maraganore
BRD | Director/Board Member | 60 | 01/01/23 |
Elena Ridloff
BRD | Director/Board Member | 44 | 12/03/21 |
Bruce Booth
FOU | Founder | 49 | 01/09/15 |
Pamela Esposito
BRD | Director/Board Member | 50 | 04/09/20 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 01/07/20 |
Leigh Morgan
BRD | Director/Board Member | 56 | 08/07/22 |
Victor Sandor
BRD | Director/Board Member | 57 | 03/11/22 |
Nello Mainolfi
FOU | Founder | 45 | 01/09/15 |
Director/Board Member | 35 | 01/03/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 61 358 262 | 60 551 699 ( 98,69 %) | 0 | 98,69 % |
Coordinate società
![Indirizzo Kymera Therapeutics, Inc.(KYMR)](https://cdn.zonebourse.com/static/address/111169997.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,81% | 1,86 Mrd | |
+18,97% | 45,34 Mrd | |
+41,98% | 40,42 Mrd | |
-10,06% | 37,92 Mrd | |
+31,15% | 31,75 Mrd | |
-7,79% | 27,71 Mrd | |
+13,32% | 26,52 Mrd | |
+43,05% | 13,96 Mrd | |
+31,28% | 12,44 Mrd | |
-7,41% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione KYMR
- Società Kymera Therapeutics, Inc.